Andrew Xiuxuan Zhu
0000-0003-4873-5033
Publication & Citation Trends
Publications
0 total
Association of tumor response with survival in patients with unresectable hepatocellular carcinoma treated with first-line tislelizumab versus sorafenib: results from the RATIONALE-301 study
Cited by 0
Semantic Scholar
Impact of baseline liver function on overall survival (OS) and safety in patients (pts) with unresectable hepatocellular carcinoma (HCC) treated with first-line (1L) tislelizumab (TIS): results from the RATIONALE-301 study
Cited by 0
Semantic Scholar
CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation OA
Cited by 51
Semantic Scholar
Albumin-Bilirubin Grade Analyses of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: A Post Hoc Analysis of the Phase III IMbrave150 Study OA
Cited by 59
Semantic Scholar
Uliledlimab and toripalimab combination therapy in treatment naive advanced NSCLC: Phase 1b/2 clinical trial results using CD73 as a potential predictive biomarker.
Cited by 5
Semantic Scholar
Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma OA
Cited by 28
Semantic Scholar
Tislelizumab versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: Impact on health-related quality of life in RATIONALE-301 population.
Cited by 2
Semantic Scholar
Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies OA
Cited by 24
Semantic Scholar
Research Topics
Hepatocellular Carcinoma Treatment and Prognosis
(364)
Cholangiocarcinoma and Gallbladder Cancer Studies
(242)
Pancreatic and Hepatic Oncology Research
(141)
Colorectal Cancer Treatments and Studies
(126)
Cancer Immunotherapy and Biomarkers
(93)
Affiliations
University of Pisa
Boston University
Northwestern University
Hospital for Special Surgery
Brigham and Women's Hospital
External Profiles
Continue on JournalsHub
Put what you just read into practice with these free tools.